Randall Children's Hospital at Legacy Emanuel — Portland, Oregon

Randall Children's Hospital at Legacy Emanuel is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Randall Children's Hospital at Legacy Emanuel has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Juvenile Idiopathic Arthritis, Polyarticular Juvenile Rheumatoid Arthritis, Arthritis, Juvenile Idiopathic.

Sponsors: Pfizer, Hackensack Meridian Health, Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Randall Children's Hospital at Legacy Emanuel?

Randall Children's Hospital at Legacy Emanuel has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Randall Children's Hospital at Legacy Emanuel conducted?

Randall Children's Hospital at Legacy Emanuel has 9 clinical trials on record, with 2 currently active. Their work covers Juvenile Idiopathic Arthritis, Polyarticular Juvenile Rheumatoid Arthritis, Arthritis, Juvenile Idiopathic.

Is Randall Children's Hospital at Legacy Emanuel accredited by Crixeo Clinical Trials?

Randall Children's Hospital at Legacy Emanuel has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Randall Children's Hospital at Legacy Emanuel?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.